2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tong Lee: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) OND-PR002 and MPh-IR, Placebo: Two dextrose capsules for Ond-PR002 and MPh-IR - Methamphetamine Dependence, Cocaine Dependence | Phase 2 | Completed | Tong Lee | 30 | 2011-08-01 | 2014-10-07 |
| Open-label, Normal Healthy Volunteer Clinical Trial of a Novel Ondansetron Formulation Ond-PR1, Ond-PR1 + MPh-IR, Ond-PR2 - Healthy | Phase 1 | Completed | Tong Lee | 6 | 2010-12-01 | 2014-08-01 |
Methylphenidate (2) · Ondansetron (2)
United States (2)
Ashwin A Patkar, MD (1) · Ashwin Patkar, MD (1) · Robert J Noveck, MD,PhD (1) · Robert Noveck, MD, PhD (1)
1RC2DA028905-01 (1)